Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02254564 · ClinicalTrials.gov registry record

PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei

A clinical trial, sponsored by Seton Healthcare Family.

Completed
Registry status
17
Enrollment target

NCT02254564: Completed study, sponsored by Seton Healthcare Family.

NCT02254564 is a clinical trial that has completed, run by Seton Healthcare Family. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02254564 has completed, sponsored by Seton Healthcare Family.

COMPLETED
Registry status
17 participants
Enrollment target

Study Summary

The main objective of this study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through PCR.

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2014-10
Est. Completion 2017-10-31
Seton Healthcare Family

15 total trials

What the finished NCT02254564 record still lists

NCT02254564 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02254564 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02254564 about?

NCT02254564 is a clinical study titled "PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei". The main objective of this study is to identify unique DNA sequences within the genome of human scabies that can be utilized to identify the parasite through PCR.

What is the current status of trial NCT02254564?

This trial is currently completed. The enrollment target is 17 participants. The study started on 2014-10. Estimated completion is 2017-10-31.

Who is sponsoring clinical trial NCT02254564?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02254564, the US trial registry maintained by the National Library of Medicine. NCT02254564 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.